Beliefs may hinder HIV prevention among African-Americans

January 25, 2005

CORVALLIS, Ore. - A new study suggests that a number of African Americans are distrustful of the government's role in the origin and treatment of HIV/AIDS - and that African American men who have such beliefs also have more negative attitudes toward condoms and use them less consistently.

The study was funded by the National Institutes of Child Health and Human Development, one of the National Institutes of Health. It was published this week in the Journal of Acquired Immune Deficiency Syndromes.

It is the believed to be the first study to examine a wide range of HIV/AIDS conspiracy beliefs and their relationship with condom use.

"These 'conspiracy theories' have been out there for a while and are part of a larger distrust of government, as well as of medical and public health institutions, by many African Americans," said Sheryl Thorburn, an associate professor of public health at Oregon State University and co-author of the study. "But this is one of the first studies to show that these beliefs about HIV/AIDS may be affecting behavior."

The researchers conducted a national telephone survey with 500 randomly selected African Americans, ages 15-44. Included in the survey were questions about HIV/AIDS beliefs, attitudes toward condoms, and condom use.

More than half (53.4 percent) of those surveyed said they believe that there is a cure for AIDS, but that it is being withheld from the poor. Only 37 percent felt that the government was telling the truth about AIDS. Among the other findings:
  • 43.6 percent of African Americans surveyed felt that people who take new medicines for HIV are human guinea pigs for the government;
  • 26.6 percent said AIDS was produced in a government laboratory;
  • 48.2 percent believed that HIV is a man-made virus;
  • 15.2 percent said AIDS is a form of genocide against blacks. "We need more open discussion about these beliefs, because they are very real," Thorburn said.

    The study found that conspiracy beliefs were associated with negative attitudes toward condoms and with inconsistent condom use among African American men - regardless of socio-demographic characteristics, perceived risk and other factors. The researchers did not find the same results for women in the survey.

    Thorburn conducted the study with Laura M. Bogart, a researcher with the RAND Corporation in Santa Monica, Calif. They said their results suggest that conspiracy beliefs may have a negative impact on HIV preventive practices.

    Researchers believe that HIV/AIDS conspiracy beliefs stem from well-documented racial discrimination and disparities in health care - as well as past examples of unethical research, including the infamous Tuskegee Syphilis Study in the mid-20th century, the authors say. In the Tuskegee study, which took place from 1932-72, the U.S. Public Health Service studied the effects of untreated syphilis in nearly 400 low-income African American males from rural Alabama. The men were told they were being treated for "bad blood" and were denied treatment for the disease.

    Distrust of the government's role in HIV may translate into distrust of public health prevention messages about HIV and condoms, Bogart said.

    "Public health professionals need to acknowledge conspiracy beliefs and work toward addressing them," Bogart said. "It is critical to have people from the community delivering messages about HIV/AIDS transmission and prevention methods." African Americans have a disproportionately high rate of HIV and AIDS, the authors point out, and addressing barriers to prevention is critical in changing that trend.
    -end-
    By Mark Floyd, 541-737-0788
    SOURCE: Sheryl Thorburn, 541-737-9493

    Oregon State University

    Related HIV Articles from Brightsurf:

    BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
    Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

    The Lancet HIV: Study suggests a second patient has been cured of HIV
    A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

    Children with HIV score below HIV-negative peers in cognitive, motor function tests
    Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

    Efforts to end the HIV epidemic must not ignore people already living with HIV
    Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

    The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
    This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

    The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
    A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

    Starting HIV treatment in ERs may be key to ending HIV spread worldwide
    In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

    NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
    Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

    The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
    Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

    Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
    Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

    Read More: HIV News and HIV Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.